Salicylate-induced bleeding problem in ophthalmic plastic surgery.
【연구 목적】 비증상성 망막혈관종양(PCV)을 가진 환자가 눈꺼풀 수술 후 아스피린 섭취로 인해 중증 출혈성 경향을 보인 사례를 통해, 살리실산염이 혈소판 기능에 미치는 영향과 관련 합병증의 기전을 규명하고자 하였다.
APA
Paris GL, Waltuch GF (1982). Salicylate-induced bleeding problem in ophthalmic plastic surgery.. Ophthalmic surgery, 13(8), 627-9.
MLA
Paris GL, et al.. "Salicylate-induced bleeding problem in ophthalmic plastic surgery.." Ophthalmic surgery, vol. 13, no. 8, 1982, pp. 627-9.
PMID
7133605
Abstract
A 54-year-old woman with clinically asymptomatic PCV underwent eyelid surgery. Twenty-four hours after an uncomplicated procedure she had a severe bleeding diathesis following the ingestion of a small amount of aspirin. Treatment of her bleeding disorder and a review of the effects of salicylates on platelet function are discussed.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | eyelid surgery
|
안검성형술 | dict | 1 | |
| 해부 | eyelid
|
눈꺼풀 | dict | 1 | |
| 해부 | platelet
|
scispacy | 1 | ||
| 약물 | aspirin
|
C0004057
aspirin
|
scispacy | 1 | |
| 질환 | bleeding
|
C0019080
Hemorrhage
|
scispacy | 1 | |
| 질환 | bleeding diathesis
|
C0005779
Blood Coagulation Disorders
|
scispacy | 1 | |
| 기타 | PCV
|
scispacy | 1 |
MeSH Terms
Aspirin; Bleeding Time; Blood Platelets; Eyelid Diseases; Eyelids; Female; Hemorrhage; Humans; Middle Aged; Polycythemia Vera; Postoperative Complications; Surgery, Plastic
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (2)
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Mohs Surgery Defect Closure Using Blepharoplasty.
- Are large language models consistent with the ASPS and AAPS guidelines? A comparison of AI chatbot recommendations and plastic surgery clinical guidance.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.